MOH

ACCE-researched
Molina Healthcare Inc Common Stock
Healthcare · Healthcare Plans · NYSE · United States
$197.80-1.49%
Market cap $10.3BNext earnings 2026-10-21Updated Sep 20, 2026
FAIR VALUE · CONSENSUS
$197.80+0.0%
confidence-weighted across 5 of 6 models
Now $197.80
$197.80
$122.65$358.89
HoldSilver64
Price vs fair value
6.2% below
+6.6% to fair value
ACCE score
40
out of 100
Analysts
44% buy
16 covering
P/E
1236.3x
forward 20.3x
1-year return
+12.9%
Dividend yield
0.00%
Unlock the ACCE read
INVESTOR

Overview

Reports in 29 days, last quarter beat by 0.1%.

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Price

+8.8% · 1Y

Valuation

INVESTOR
Full valuation engine INVESTOR FEATURE

Six independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.

  • +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
  • +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
  • +Editable DCF workbench with saved scenarios

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.

  • +Conviction score breakdown and earnings-quality grade
  • +Growth / value / quality / momentum component scores
  • +90-day score history and score-threshold backtests

Analysts

Wall Street consensus

Mixed44% buy · 16 covering analysts
● Strong buy 6● Buy 1● Hold 8● Sell 1● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO
Smart money tracking PRO FEATURE

Follow the institutions: 13F position changes, insider trades, and active 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Recent open-market insider transactions
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

This stock Peer Peer median weaker → stronger
P/Ebetter than 0% of peers
low 24.1x1236.3xhigh 1236.3x
ROEbetter than 33% of peers
low -20%-0%high 34%
Div yieldbetter than 83% of peers
low 0.0%0.0%high 0.9%

Algorithmic peers (6)

TickerCompanyMcapP/EROED/EYieldQuality
OSCROscar Health Inc. Class A Common Stock$9.7B24.134.3%0.440.0%-Compare
CNCCentene Corporation Common Stock$32.1B--20.4%0.870.0%-Compare
CLOVClover Health Investments Corp. Class A Common Stock$2.4B--5.1%-0.250.0%-Compare
HUMHumana Inc. Common Stock$45.5B35.86.9%0.700.9%-Compare
PGNYProgyny Inc. Common Stock$2.1B29.216.2%0.010.0%-Compare
ALHCAlignment Healthcare Inc. Common Stock$1.7B43.820.0%1.810.0%-Compare

Sector report card

Where MOH ranks against its sector peers on each metric.

Computing percentiles…

News and Record

Reports in 29 days, last quarter beat by 0.1%.

Press releases mentioning this company

Ask anything, Pro feature

Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.

PRO

Recent performance

1 week
-7.6%
1 month
-1.2%
3 months
+0.6%
6 months
+41.4%
YTD
+14.0%
1 year
+12.9%

SEC filings

40 filings
July 2026
Jul 23
10-QQuarterly reportPeriod 2026-06-30
Jul 22
8-KCurrent reportPeriod 2026-07-22
Jul 2
Form 4Insider transactionPeriod 2026-07-01
37 more filings + AI summaries on Investor+.INVESTOR

Recent ACCE blog coverage